Keywords: butyric acid; NF-E2; GATA-1; erythroid genes; leuke- In the human K562 leukemic cell line, 2 BA has been K562 cells were cultured in RPMI-1640 medium (Life Technoreported to induce an increase, either of the activity of heme logies, St Quentin en Yvelines, France) supplemented with biosynthesis enzymes such as ␦-aminolevulinate synthase 10% heat-inactivated fetal bovine serum and 2 mM L-gluta-(ALAS 3 ), ␦-aminolevulinate dehydratase (ALAD 4, 5 ) and mine, in a 5% CO 2 humidified atmosphere. porphobilinogen deaminase (PBGD 5 ), or of glycophorin-A expression, a membrane-specific protein of red blood cells. Nevertheless, neither these recent results nor former report 7 Assays for cell growth and erythroid differentiation mentioned short-term kinetics analysis of BA-differentiating effect. Furthermore, although ␥-globin mRNA level has been Cells were treated with BA, or other inducers, at the beginning found to increase in sodium butyrate-treated K562 cells, of this exponential growth phase. Cell growth and viability owing to a transcriptional activation 6 and an enhancement of were assessed by direct counting of trypan blue dye-excluding promoter activity, 8, 9 no information is yet available concerncells. Growth inhibition was calculated from ing BA action on erythroid transcription factors NF-E2 and GATA-1.
All chemical reagents were purchased from Sigma (St Quentin Fallavier, France) unless otherwise stated and were of reagent Introduction grade or molecular biology grade when necessary. n-Butyric acid solution was diluted to 100 mm in water and sterilized Butyric acid (BA) is a widely used short-chain fatty acid which through 0.22 m filters (Millipore, St Quentin en Yvelines, demonstrated a variety of effects both in vivo and in tumoral France). cell lines. BA induces cell growth arrest, changes in cell morphology, induction of erythroid differentiation of erythroleukemic cell lines and especially induction of fetal hemoCell culture globin synthesis. 1 In the human K562 leukemic cell line, 2 BA has been K562 cells were cultured in RPMI-1640 medium (Life Technoreported to induce an increase, either of the activity of heme logies, St Quentin en Yvelines, France) supplemented with biosynthesis enzymes such as ␦-aminolevulinate synthase 10% heat-inactivated fetal bovine serum and 2 mM L-gluta-(ALAS 3 ), ␦-aminolevulinate dehydratase (ALAD 4, 5 ) and mine, in a 5% CO 2 humidified atmosphere. porphobilinogen deaminase (PBGD 5 ), or of glycophorin-A expression, a membrane-specific protein of red blood cells. 3 Nevertheless, neither these recent results nor former report 7 Assays for cell growth and erythroid differentiation mentioned short-term kinetics analysis of BA-differentiating effect. Furthermore, although ␥-globin mRNA level has been Cells were treated with BA, or other inducers, at the beginning found to increase in sodium butyrate-treated K562 cells, of this exponential growth phase. Cell growth and viability owing to a transcriptional activation 6 and an enhancement of were assessed by direct counting of trypan blue dye-excluding promoter activity, 8, 9 no information is yet available concerncells. Growth inhibition was calculated from ing BA action on erythroid transcription factors NF-E2 and GATA-1.
{ The heterodimeric NF-E2 transcription factor 10,11 recogwhere C n , C 0 , T n , T 0 represent the numbers of cells/ml at days nizes an extended AP-1 site initially characterized in the 0 and n, respectively. The percentage of hemoglobin-PBGD gene promoter 12 and in the locus control region of the producing cells was determined by a benzidine staining human ␤-globin gene. 13 Despite mild effects on erythropoiesis method as previously described. 17 of p45 NF-E2 suppression in knockout mice, 14 the depen-containing 1% agarose gel electrophoresis and capillary blotwith the optimal differentiation-inducing concentration, BA 0.5 mM, which exhibited a cytostatic effect, and BA 1 mM, ted onto a nylon membrane (Hybond N; Amersham, Les Ulis, France). Random priming labeling of cDNA probes was perwhich combined a maximal growth inhibitory effect with a low cytotoxicity (90% of viable cells). formed using the Ready-To-Go DNA labeling kit (Pharmacia Biotech, St Quentin en Yvelines, France) and ␣-32 P-dCTP Hemoglobinization of K562 cells was studied as a function of time by scoring benzidine-positive cells after 2 to 72 h of (3000 Ci/mmol; DuPont NEN, Les Ulis, France). Membranes were then hybridized with labeled cDNA according to the treatment with 0.5 and 1.0 mM BA. The percentage of differentiated cells increased in a time-dependent manner for both supplier's instructions. The A ␥-globin, EPOR and GATA-1 human cDNAs were a kind gift from Dr S Ottolenghi concentrations, and was significantly increased as soon as 10 h after treatment with 0.5 mM BA (Figure 2a ). Cell prolifer-(University of Milan, Italy), human PBGD and murine p45 NF-E2 cDNAs were from Dr P-H Roméo (Hô pital Henri Mondor, ation was not affected before 12 h of treatment (Figure 2b) , then, as soon as 24 h, both BA concentrations induced a cell Créteil, France) and Dr SH Orkin (Harvard Medical School, Boston, MA, USA), respectively. Finally membranes were growth inhibitory effect of 20% to reach 60% and 71%, respectively, at 72 h. dehybridized in boiling 0.1% SDS and reprobed with human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA
In order to investigate the reversibility of the BA-differentiating effect, K562 cells were treated by 0.5 and 1 mM BA for from Clontech (Montigny le Bretonneux, France). Northern blots were quantified using a GS363 molecular imager 24 h and then incubated in complete drug-free medium for an additional 24 or 48 h before scoring the benzidine-positive (BioRad, Ivry sur Seine, France) and submitted to autoradiography.
cells. Hemin (30 M), which did not affect cell proliferation, was used as a control of reversible induction as previously described. 18 Anthracyclines (aclarubicin and doxorubicin) have been demonstrated to be potent differentiating agents in Results and discussion K562 cells (reviewed in Ref. 19) and were used at optimal differentiating concentrations as irreversible inducers. The
Effect of BA on cell growth and differentiation results presented in Table 1 showed that BA-induced differentiation and cell growth inhibition were irreversible, at least for Exponentially growing K562 cells were treated with 0.25-2 mM BA for 3 days and cell hemoglobinization was studied by scoring benzidine-positive cells. As shown in Figure 1 , the increase of benzidine-positive cells was gradual and reached a maximum of 54% of hemoglobinized cells with 0.5 mM BA vs 3% in control cells. In contrast, higher concentrations (1 to 2 mM) resulted in a decline in the percentage of hemoglobinized cells followed by an increase of cell mortality which went up to 39% in 2 mM BA-treated cells vs 5% in both 0.5 mM BA-treated and untreated cells (Figure 1 ). In addition, cell proliferation was strongly affected by BA treatment, and a 60% growth inhibition was observed with 0.25 mM BA, increasing up to a plateau of 87% with 1 mM BA. Consequently, further differentiation analyses were performed both 72 h, in contrast to hemin-induced hemoglobinization which on the surface of aclarubicin-treated cells was augmented. 22 In contrast, we did not observe any increase of EPOR mRNA requires the continuous presence of the drug.
Consequently, although more rapid, BA-inducing effects in K562 cells treated for 6 to 72 h with 0.5 and 1 mM BA (Figure 4) , thus ruling out a putative role of EPOR in BAshare some similarities with those of anthracyclines, particularly aclarubicin. 19 Indeed, BA as well as anthracyclines induced differentiation of K562 cells. induce irreversible, time-and dose-dependent hemoglobinization and cell growth inhibition. Moreover, like aclarubicin, but in contrast with doxorubicin, 17, 19 BA did not require the BA-induced increase of erythroid transcription factor mRNA level total arrest of cell growth to induce optimal hemoglobinization of K562 cells. The erythroid transcription factors NF-E2 and GATA-1 have been previously shown to be increased during aclarubicin-, but not doxorubicin-induced differentiation of K562
Effect of BA on erythroid gene expression cells. 20, 23, 24 In an attempt to better understand the involvement of these transcription factors, we used p45 NF-E2 and ␥-Globin mRNA expression was studied in 0.5 mM and 1 mM BA-treated cells for 6 to 72 h. Hybridization of Northern blots GATA-1 cDNAs to investigate their mRNA expression timecourses during BA-induced differentiation of K562 cells. with 32 P-labeled cDNA showed that ␥-globin expression increased as soon as 6 h (1.5-fold) after BA treatment ( Figure  As shown in Figure 3 , p45 NF-E2 mRNA level was increased as early as 6 h (1.2-fold) to reach a maximum of 3). This effect was time-dependent with a maximum of sixfold at 72 h, in accordance with previous results. 6 This marked three-fold at 72 h after 0.5 mM BA treatment ( Figure 3 ). With 1 mM BA the maximal increase in p45 NF-E2 mRNA was increase of ␥-globin mRNA correlated with cell hemoglobinization, since benzidine-positive cells appeared 4 h after the obtained much earlier (as soon as 12 h after treatment) and was enhanced up to three-fold (data not shown). It should be increase of ␥-globin mRNA. An upregulation of ␥-globin mRNA was also observed in cells treated with 1 mM BA with noted that the time-course of p45 NF-E2 mRNA increase paralleled that of PBGD and that of cell hemoglobinization approximately the same efficiency (data not shown).
Concerning the heme synthesis pathway, PBGD gene (Figures 3b and 2a) . In contrast, GATA-1 mRNA slightly increased during the expression was increased by 1.5-fold in 0.5 mM BA-treated cells as soon as 12 h, with a maximum of two-fold at 72 h time-course of BA treatment, with a maximum of 1.3-fold at 12 h ( Figure 3 ) and then decreased. The use of 1 mM BA (Figure 3 ). According to Fowler et al, 5 this indicates that, in BA-treated cells, the PBGD mRNA increase is lower than that instead of 0.5 mM did not amplify the GATA-1 mRNA increase which remained below 1.5-fold (data not shown). of ␥-globin. In addition, the time-course of PBGD mRNA increase paralleled that of hemoglobinized cells. This obser-
In conclusion, these results showed the rapid effect of BA on erythroid gene expression, with the major exception of the vation is in agreement with that of Kawasaki et al 3 who reported that ALAS activity and hemoglobin levels were simul-EPOR gene, and the correlation between ␥-globin, PBGD and p45 NF-E2 mRNA expression and cell hemoglobinization taneously increased to a similar extent and with a similar timecourse in sodium butyrate-treated K562 cells.
time-courses. Contrasting with the mildness of the GATA-1 mRNA increase, the early and marked increase of p45 NFThe EPOR gene, like PBGD and ␥-globin genes, has been previously found to be transcriptionally activated in aclarubi-E2 mRNA level is consistent with a transcriptional activation process and suggests an important role of this transcription cin-differentiated K562.
20,21 Moreover, the EPOR expression factor. Nevertheless, the involvement in BA-triggered differentiation of NF-E2, GATA-1, as well as other transcription factors such as EKLF, remains to be directly demonstrated.
